InvestorsHub Logo
Followers 6
Posts 607
Boards Moderated 0
Alias Born 02/25/2017

Re: KeepItRealistic post# 11099

Sunday, 10/01/2017 2:30:02 PM

Sunday, October 01, 2017 2:30:02 PM

Post# of 22035
Like the R&D PIPELINE with Apotheca

On September 15, 2017, the Company purchased 20% of Apotheca Biosciences, Inc. for an undisclosed amount. Apotheca Biosciences is developing cutting-edge medical products, nutraceuticals, formulation and delivery technologies for the healthcare and consumer care industry. Their pipeline of products includes, transdermal, sublingual, and nasal delivery technologies for precise and controlled dosing of cannabinoids.

 


25202320211200274207